Plain-language summary
Exosomes released by non-small cell lung cancer cells were found to carry the long non-coding RNA LINC00467 into surrounding fibroblasts. In co-culture, that transfer moved normal MRC5 fibroblasts and cancer-associated fibroblasts towards an activated state, with higher alpha-smooth muscle actin and type I and type III collagen and faster proliferation. LINC00467 behaved as a sponge for miR-133b: silencing it in the cancer cells lowered exosomal LINC00467 and raised miR-133b in the recipient fibroblasts, and an miR-133b inhibitor restored the activated phenotype. Fibroblasts pre-treated with the exosomes in turn helped A549 cancer cells proliferate, colonise and migrate.
Key findings
- Non-small cell lung cancer cells package the long non-coding RNA LINC00467 into exosomes and transfer it to fibroblasts.
- Recipient MRC5 fibroblasts and cancer-associated fibroblasts shifted towards an activated state, expressing more alpha-smooth muscle actin and type I and type III collagen.
- Exosomal LINC00467 also increased Cyclin B1 and Cyclin D1 and accelerated fibroblast proliferation.
- LINC00467 appears to act as a miR-133b sponge; its silencing raised miR-133b in recipient fibroblasts.
- An miR-133b inhibitor reversed the effect of LINC00467 silencing, supporting the proposed lncRNA/miRNA axis.
- Fibroblasts primed by these exosomes enhanced A549 proliferation, colony formation and migration. The work is cell-culture based.
Why this matters for lung repair
Fibroblast activation is the shared endpoint of two different problems in the lung: tumour stroma formation and fibrotic remodelling. This study shows that a cancer cell can push that switch from a distance by exporting a single non-coding RNA inside an exosome, and then dissects the downstream microRNA step. Knowing which molecules travel in which vesicles is a prerequisite for any research into vesicle-based delivery in the lung. The findings come from cell culture and do not yet show this axis operating in patients.
Original abstract
Cancer-associated fibroblasts (CAFs) significantly contribute to non-small cell lung cancer (NSCLC) progression by remodeling the extracellular matrix and mediating paracrine signaling. Although exosomal lncRNAs are key regulators of tumor-stroma interactions, the specific functions of individual lncRNAs remain poorly understood. LINC00467 and miR-133b were selected for further investigation in this study based on previous reports, prior evidence of lncRNA-miRNA interaction, and preliminary experimental observations in NSCLC-derived exosomes and fibroblast activation models. Exosomes from A549 and primary NSCLC cells were isolated using a polymer-based precipitation method and validated by Western blotting. LINC00467 was silenced via siRNA, and isolated exosomes were co-cultured with MRC5 fibroblasts and CAFs. Fibroblast activation and proliferation markers were assessed by Western blotting and cell counting kit assays. miR-133b involvement was examined using quantitative real-time PCR and inhibitor-based rescue experiments. Exosome-pretreated MRC5 fibroblasts were also co-cultured with A549 cells. Exosomal LINC00467 was enriched in NSCLC-derived exosomes. Knockdown of LINC00467 in NSCLC cells reduced its exosomal levels, leading to decreased expression of activation markers (α-SMA, COL-I, COL-III) and cell cycle regulators (Cyclin B1, Cyclin D1) in recipient fibroblasts. In addition, exosomes with LINC00467 knockdown inhibited the cell proliferation of fibroblasts. It was also revealed that LINC00467-deficient exosomes upregulated miR-133b expression. Importantly, inhibition of miR-133b reversed the suppressive effects of LINC00467 knockdown. Exosome-pretreated fibroblasts enhanced A549 cell proliferation, colony formation, and migration in vitro. This study identifies a novel exosomal LINC00467/miR-133b axis that promotes fibroblast activation and proliferation in NSCLC.
Frequently asked questions
What did this study find?
Exosomes released by non-small cell lung cancer cells were found to carry the long non-coding RNA LINC00467 into surrounding fibroblasts. In co-culture, that transfer moved normal MRC5 fibroblasts and cancer-associated fibroblasts towards an activated state, with higher alpha-smooth muscle actin and type I and type III collagen and faster proliferation. LINC00467 behaved as a sponge for miR-133b: silencing it in the cancer cells lowered exosomal LINC00467 and raised miR-133b in the recipient fibroblasts, and an miR-133b inhibitor restored the activated phenotype. Fibroblasts pre-treated with the exosomes in turn helped A549 cancer cells proliferate, colonise and migrate.
Was this tested in humans or in the laboratory?
This is preclinical work — the findings come from laboratory models, not from human participants.
Where can I read the original paper?
The full text lives with the publisher: https://doi.org/10.1007/s12013-026-02170-5
Does this study prove that JuvGuard works?
No. This is an independent, peer-reviewed study on extracellular vesicles. JuvGuard references the published literature for education only. A single paper cannot establish that any product works, and nothing here is medical advice.
How to cite this paper
Li Zengyao, Wu Yan, Niu Sen, Chang Yanhua, Lu Rongguo, Bian Tao et al.. Exosomes Derived from Non-small Cell Lung Cancer Cells Transfer LINC00467 to Induce the Proliferation of Cancer-associated Fibroblasts.. Cell biochemistry and biophysics. 2026, 2026-09-23. DOI: 10.1007/s12013-026-02170-5
Source & verification
- Journal: Cell biochemistry and biophysics
- Published: 23 September 2026
- DOI: 10.1007/s12013-026-02170-5
- PubMed ID: 42776375
- Indexed via: pubmed
- MeSH terms: —